INS and cancer: These resultsare controversial since it was unclear whether the increased mortality risk is a resultof use of both insulin and sulfonylurea, or that metformin use decreased the risk.31 Other studies found that not onlydid the use of sulfonylurea and insulin increase the risk for cancer-related death ascompared with metformin use, it also increased the risk for cancer development.